As such, the Jun pathway was also recognized to be affected by the BCR-ABL kinase, but it is not clear that this is strongly implicated in Bcr-Abl kinase action within the context of CML. The gene discussed is JUN; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.